Table of Contents

Review Articles

• You have access

  Antibody Drug Conjugates for Cancer Therapy

  Paul Polakis

  Timothy A. Esbenshade, ASSOCIATE EDITOR, Department of Molecular Oncology, Genentech, South San Francisco, California

  Pharmacological Reviews January 2016, 68 (1) 3-19; DOI: https://doi.org/10.1124/pr.114.009373
• You have access

  Mitochondrial Quality Control as a Therapeutic Target

  Hagir B. Suliman and Claude A. Piantadosi

  Mark P. Mattson, ASSOCIATE EDITOR, Departments of Medicine (C.A.P.), Anesthesiology (H.B.S.), Duke Cancer Institute (H.B.S.), and Pathology (C.A.P.), Duke University Medical Center, Durham North Carolina

  Pharmacological Reviews January 2016, 68 (1) 20-48; DOI: https://doi.org/10.1124/pr.115.011502
• You have access

  Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology

  F. Jaisser and N. Farman

  Rhian M. Touyz, ASSOCIATE EDITOR, INSERM UMR 1138 Team 1, Cordeliers Research Center, Pierre et Marie Curie University, Paris, France (F.J., N.F); and University Paris-Est Creteil, Creteil, France (F.J.)

  Pharmacological Reviews January 2016, 68 (1) 49-75; DOI: https://doi.org/10.1124/pr.115.011106
• You have access

  Pharmacology of Heparin and Related Drugs

  Barbara Mulloy, John Hogwood, Elaine Gray, Rebecca Lever and Clive P. Page

  David R. Sibley, ASSOCIATE EDITOR, Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King’s College London, London, United Kingdom (B.M., C.P.P.); National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom (J.H., E.G.); and University College London School of Pharmacy, London, United Kingdom (R.L.)

  Pharmacological Reviews January 2016, 68 (1) 76-141; DOI: https://doi.org/10.1124/pr.115.011247
• You have access

  Toll-like Receptors in the Vascular System: Sensing the Dangers Within

  Styliani Goulopoulou, Cameron G. McCarthy and R. Clinton Webb

  Stephanie W. Watts, ASSOCIATE EDITOR, Institute for Cardiovascular and Metabolic Diseases, Department of Obstetrics and Gynecology, University of North Texas Health Science Center, Fort Worth, Texas; and Department of Physiology, Augusta University, Augusta, Georgia

  Pharmacological Reviews January 2016, 68 (1) 142-167; DOI: https://doi.org/10.1124/pr.114.010090
• You have access

  Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions

  Janne T. Backman, Anne M. Filppula, Mikko Niemi and Pertti J. Neuvonen

  Markku Koulu, ASSOCIATE EDITOR, Department of Clinical Pharmacology, University of Helsinki (J.T.B., A.M.F., M.N., P.J.N.), and Helsinki University Hospital, Helsinki, Finland (J.T.B., M.N., P.J.N.)

  Pharmacological Reviews January 2016, 68 (1) 168-241; DOI: https://doi.org/10.1124/pr.115.011411